Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-035701

Chief Financial Officer sold 30,000 shares at an average $39.35 ($1,180,518)

  • Chief Financial Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-06-08 Option exercise +21,250 $6.32 $134,300 22,250 D: show line 1 in the form
Cohen Chad M Chief Financial Officer 2020-06-08 Sale −18,805 $38.99 $733,207 3,445 D: show line 2 in the form
Cohen Chad M Chief Financial Officer 2020-06-08 Sale −2,445 $39.80 $97,311 1,000 D: show line 3 in the form
Cohen Chad M Chief Financial Officer 2020-06-09 Option exercise +8,750 $6.32 $55,300 9,750 D: show line 4 in the form
Cohen Chad M Chief Financial Officer 2020-06-09 Sale −8,750 $40.00 $350,000 1,000 D: show line 5 in the form
Open-market sales · 30,000 sh · avg $39.35 · $1,180,518

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-06-08 Option exercise · Stock Option (Right To Buy) −21,250 678,750 D: show line 6 in the form
Cohen Chad M Chief Financial Officer 2020-06-09 Option exercise · Stock Option (Right to Buy) −8,750 670,000 D: show line 7 in the form
Loading xslF345X03/doc4.xml…